Supplementation of lactobacillus plantarum K68 and fruit-vegetable ferment along with high fat-fructose diet attenuates metabolic syndrome in rats with insulin resistance

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Huang, Hui Yu ^a   Korivi, Mallikarjuna ^b,c   Tsai, Chun Han ^a   Yang, Jo Hsuan ^a   Tsai, Ying Chieh ^d  

^a SHIH CHIEN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TPEC   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FRUCTOSE; FRUIT VEGETABLE FERMENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; PLANT MEDICINAL PRODUCT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARBOHYDRATE DIET; CONTROLLED STUDY; ENZYME ACTIVITY; FERMENTED PRODUCT; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LACTOBACILLUS PLANTARUM; LIPID DIET; MALE; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84877282635     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/943020     Document Type: Article

References (47)

1. Miranda P. J., DeFronzo R. A., Califf R. M., Guyton J. R., Metabolic syndrome: definition, pathophysiology, and mechanisms. American Heart Journal 2005 149 1 33 45 2-s2.0-12344304272 10.1016/j.ahj.2004.07.013 (Pubitemid 40126488)
2. Elliott S. S., Keim N. L., Stern J. S., Teff K., Havel P. J., Fructose, weight gain, and the insulin resistance syndrome. American Journal of Clinical Nutrition 2002 76 5 911 922 2-s2.0-0036828347 (Pubitemid 35244659)
3. Potenza M. V., Mechanick J. I., The metabolic syndrome: definition, global impact, and pathophysiology. Nutrition in Clinical Practice 2009 24 5 560 577 2-s2.0-74049154021 10.1177/0884533609342436
4. Odermatt A., The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. American Journal of Physiology-Renal Physiology 2011 301 5 F919 F931
5. Matsuzawa-Nagata N., Takamura T., Ando H., Nakamura S., Kurita S., Misu H., Ota T., Yokoyama M., Honda M., Miyamoto K. I., Kaneko S., Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 2008 57 8 1071 1077 2-s2.0-47149115165 10.1016/j.metabol.2008.03.010 (Pubitemid 351978066)
6. Kannappan S., Palanisamy N., Anuradha C. V., Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by naringenin in fructose-administered rats. European Journal of Pharmacology 2010 645 1-3 177 184 2-s2.0-77956184900 10.1016/j.ejphar.2010.07.015
7. Francini F., Castro M. C., Schinella G., García M. E., Maiztegui B., Raschia M. A., Gagliardino J. J., Massa M. L., Changes induced by a fructose-rich diet on hepatic metabolism and the antioxidant system. Life Sciences 2010 86 25-26 965 971 2-s2.0-77953612672 10.1016/j.lfs.2010.05.005
8. Battcock M., Azam-Ali S., Fermented Fruits and Vegetables: A Globsl Perspective 1998 Food and Agriculture Organization
9. De Vos W. M., Hugenholtz J., Engineering metabolic highways in Lactococci and other lactic acid bacteria. Trends in Biotechnology 2004 22 2 72 79 2-s2.0-1642441286 10.1016/j.tibtech.2003.11.011 (Pubitemid 38130174)
10. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E., Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001 357 9262 1076 1079 2-s2.0-0035820307 10.1016/S0140-6736(00)04259-8 (Pubitemid 32322538)
11. Tabuchi M., Ozaki M., Tamura A., Yamada N., Ishida T., Hosoda M., Hosono A., Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Bioscience, Biotechnology and Biochemistry 2003 67 6 1421 1424 2-s2.0-2142856710 (Pubitemid 39251845)
12. Yadav H., Jain S., Sinha P. R., Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007 23 1 62 68 2-s2.0-33845667433 10.1016/j.nut.2006.09.002 (Pubitemid 44959762)
13. Naruszewicz M., Johansson M. L., Zapolska-Downar D., Bukowska H., Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. American Journal of Clinical Nutrition 2002 76 6 1249 1255 2-s2.0-18744378321 (Pubitemid 35416559)
14. Chao S. H., Tomii Y., Watanabe K., Tsai Y. C., Diversity of lactic acid bacteria in fermented brines used to make stinky tofu. International Journal of Food Microbiology 2008 123 1-2 134 141 2-s2.0-40049112761 10.1016/j.ijfoodmicro. 2007.12.010
15. Chao S. H., Wu R. J., Watanabe K., Tsai Y. C., Diversity of lactic acid bacteria in suan-tsai and fu-tsai, traditional fermented mustard products of Taiwan. International Journal of Food Microbiology 2009 135 3 203 210 2-s2.0-70349764689 10.1016/j.ijfoodmicro.2009.07.032
16. Liu Y. W., Su Y. W., Ong W. K., Cheng T. H., Tsai Y. C., Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities. International Immunopharmacology 2011 11 12 2159 2166
17. Fröhlich R. H., Kunze M., Kiefer I., Cancer preventive impact of naturally occurring, non-nutritive constituents in food. Acta Medica Austriaca 1997 24 3 108 113 2-s2.0-0030624763 (Pubitemid 27334497)
18. FDA U., Guidance for Industry, Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Center for Drug Evaluation and Research, US Department of Health and Human Services, 2005, http://www.fda.gov/cder/guidance/index.htm
19. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 6 499 502 2-s2.0-0015348189
20. Liyana-Pathirana C. M., Shahidi F., Antioxidant activity of commercial soft and hard wheat (Triticum aestivum L.) as affected by gastric pH conditions. Journal of Agricultural and Food Chemistry 2005 53 7 2433 2440 2-s2.0-16344384874 10.1021/jf049320i (Pubitemid 40471721)
21. Robak J., Gryglewski R. J., Flavonoids are scavengers of superoxide anions. Biochemical Pharmacology 1988 37 5 837 841 2-s2.0-0023864255 (Pubitemid 18058453)
22. Wolfe K., Wu X., Liu R. H., Antioxidant activity of apple peels. Journal of Agricultural and Food Chemistry 2003 51 3 609 614 2-s2.0-0037471604 10.1021/jf020782a
23. Kim N. H., Moon P. D., Kim S. J., Choi I. Y., An H. J., Myung N. Y., Jeong H. J., Um J. Y., Hong S. H., Kim H. M., Lipid profile lowering effect of Soypro ™ fermented with lactic acid bacteria isolated from Kimchi in high-fat diet-induced obese rats. BioFactors 2008 33 1 49 60 2-s2.0-65449176806 10.1002/biof.5520330105
24. Wada T., Kenmochi H., Miyashita Y., Sasaki M., Ojima M., Sasahara M., Koya D., Tsuneki H., Sasaoka T., Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. Endocrinology 2010 151 5 2040 2049 2-s2.0-77953165944 10.1210/en.2009-0869
25. Bibbins-Domingo K., Coxson P., Pletcher M. J., Lightwood J., Goldman L., Adolescent overweight and future adult coronary heart disease. The New England Journal of Medicine 2007 357 23 2371 2379 2-s2.0-37049021990 10.1056/NEJMsa073166 (Pubitemid 350244535)
26. Suwannaphet W., Meeprom A., Yibchok-Anun S., Adisakwattana S., Preventive effect of grape seed extract against high-fructose diet-induced insulin resistance and oxidative stress in rats. Food and Chemical Toxicology 2010 48 7 1853 1857 2-s2.0-77953545430 10.1016/j.fct.2010.04.021
27. Ceriello A., Testa R., Antioxidant anti-inflammatory treatment in type 2 diabetes. Diabetes Care 2009 32 S232 S236 2-s2.0-75549083004
28. Matsuzaki T., Yamazaki R., Hashimoto S., Yokokura T., Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-A(y) mice. Endocrine Journal 1997 44 3 357 365 2-s2.0-0030792512 (Pubitemid 27310421)
29. Athyros V. G., Tziomalos K., Karagiannis A., Anagnostis P., Mikhailidis D. P., Should adipokines be considered in the choice of the treatment of obesity-related health problems? Current Drug Targets 2010 11 1 122 135 2-s2.0-77949455006 10.2174/138945010790030992
30. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 2006 116 7 1784 1792 2-s2.0-33745834319 10.1172/JCI29126 (Pubitemid 44033298)
31. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., Eto K., Yamashita T., Kamon J., Satoh H., Yano W., Froguel P., Nagai R., Kimura S., Kadowaki T., Noda T., Disruption of adiponectin causes insulin resistance and neointimal formation. Journal of Biological Chemistry 2002 277 29 25863 25866 2-s2.0-0037135523 10.1074/jbc.C200251200 (Pubitemid 34967064)
32. Reifel-Miller A., Otto K., Hawkins E., Barr R., Bensch W. R., Bull C., Dana S., Klausing K., Martin J. A., Rafaeloff-Phail R., Rafizadeh-Montrose C., Rhodes G., Robey R., Rojo I., Rungta D., Snyder D., Wilbur K., Zhang T., Zink R., Warshawsky A., Brozinick J. T., A peroxisome proliferator-activated receptor α / γ dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia. Molecular Endocrinology 2005 19 6 1593 1605 2-s2.0-22344446185 10.1210/me.2005-0015 (Pubitemid 41002988)
33. Mooradian A. D., Dyslipidemia in type 2 diabetes mellitus. Nature Clinical Practice Endocrinology and Metabolism 2009 5 3 150 159 2-s2.0-60749131994 10.1038/ncpendmet1066
34. Bukowska H., Pieczul-Mroz J., Jastrzebska M., Chelstowski K., Naruszewicz M., Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis 1998 137 2 437 438 2-s2.0-0031976890 10.1016/S0021-9150(97)00283-9 (Pubitemid 28215890)
35. Kawase M., Hashimoto H., Hosoda M., Morita H., Hosono A., Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. Journal of Dairy Science 2000 83 2 255 263 2-s2.0-0034133634
36. Fukushima M., Nakano M., Effects of a mixture of organisms, Lactobacillus acidophilus or Streptococcus faecalis on cholesterol metabolism in rats fed on a fat- and cholesterol-enriched diet. British Journal of Nutrition 1996 76 6 857 867 2-s2.0-0030472219 10.1079/BJN19960092 (Pubitemid 27029126)
37. Hashimoto H., Yamazaki K., He F., Kawase M., Hosoda M., Hosono A., Hypocholesterolemic effects of Lactobacillus casei subsp, casei TMC, 0409 strain observed in rats fed cholesterol contained diets. Animal Science Journal 1999 70 90 97 (Pubitemid 129228287)
38. Rao D. R., Chawan C., Pulusani S., Influence of milk and thermophilus milk on plasma cholesterol levels and hepatic cholesterogenesis in rats. Journal of Food Science 1981 46 5 1339 1341
39. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- α: direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 (Pubitemid 23036092)
40. Cani P. D., Amar J., Iglesias M. A., Poggi M., Knauf C., Bastelica D., Neyrinck A. M., Fava F., Tuohy K. M., Chabo C., Waget A., Delmée E., Cousin B., Sulpice T., Chamontin B., Ferrières J., Tanti J. F., Gibson G. R., Casteilla L., Delzenne N. M., Alessi M. C., Burcelin R., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007 56 7 1761 1772 2-s2.0-34347399563 10.2337/db06-1491 (Pubitemid 47025442)
41. Chon H., Choi B., Lee E., Lee S., Jeong G., Immunomodulatory effects of specific bacterial components of Lactobacillus plantarum KFCC11389P on the murine macrophage cell line RAW 264 · 7. Journal of Applied Microbiology 2009 107 5 1588 1597 2-s2.0-70349975865 10.1111/j.1365-2672.2009.04343.x
42. Kern P. A., Di Gregorio G. B., Lu T., Rassouli N., Ranganathan G., Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor- α expression. Diabetes 2003 52 7 1779 1785 2-s2.0-0037677604 (Pubitemid 36792470)
43. Houstis N., Rosen E. D., Lander E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006 440 7086 944 948 2-s2.0-33645860825 10.1038/nature04634
44. Oda A., Bannai C., Yamaoka T., Katori T., Matsushima T., Yamashita K., Inactivation of Cu,Zn-superoxide dismutase by in vitro glycosylation and in erythrocytes of diabetic patients. Hormone and Metabolic Research 1994 26 1 1 4 2-s2.0-0027957605 (Pubitemid 24038359)
45. Nishikawa T., Edelstein D., Du X. L., Yamagishi S. I., Matsumura T., Kaneda Y., Yorek M. A., Beebe D., Oates P. J., Hammes H. P., Glardino I., Brownlee M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000 404 6779 787 790 2-s2.0-0034643340 10.1038/35008121 (Pubitemid 30212409)
46. Kleerebezem M., Boekhorst J., Van Kranenburg R., Molenaar D., Kuipers O. P., Leer R., Tarchini R., Peters S. A., Sandbrink H. M., Fiers M. W. E. J., Stiekema W., Klein Lankhorst R. M., Bron P. A., Hoffer S. M., Nierop Groot M. N., Kerkhoven R., De Vries M., Ursing B., De Vos W. M., Siezen R. J., Complete genome sequence of Lactobacillus plantarum WCFS1. Proceedings of the National Academy of Sciences of the United States of America 2003 100 4 1990 1995 2-s2.0-0037452621 10.1073/pnas.0337704100 (Pubitemid 36254561)
47. Archibald F. S., Fridovich I., Manganese and defenses against oxygen toxicity in Lactobacillus plantarum. Journal of Bacteriology 1981 145 1 442 451 2-s2.0-0019475137 (Pubitemid 11140325)